NCT05978401 2023-08-07Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung CancerGuangzhou Gloria Biosciences Co., Ltd.Phase 1/2 Unknown152 enrolled